Cerulean Pharma reported $-8400450 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Arrowhead Research ARWR:US USD -72909000 114.46M
Bayer BAYN:GR EUR 1.2B 1.03B
Biocept BIOC:US USD -5577000 480K
Brainstorm Cell Therapeutics BCLI:US USD -6841000 750K
Immunogen IMGN:US USD -77429000 16.38M
Johnson & Johnson JNJ:US USD 5.82B 18M
Macrogenics MGNX:US USD -24955000 16.85M
Merk MRK:US USD 3.99B 939M
Nektar Therapeutics NKTR:US USD -54301000 98.54M
Perrigo Ordinary Shares PRGO:US USD 33.5M 49.7M
Pfizer PFE:US USD 9.41B 2.69B
Seattle Genetics SGEN:US USD -192805000 59.69M
YTE INCY:US USD 138.38M 116.06M